Global, Regional, and National Burden of Chronic Myeloid Leukemia, 1990–2017: A Systematic Analysis for the Global Burden of Disease Study 2017

BACKGROUND: With the advent of tyrosine kinase inhibitors (TKIs), the prognosis of chronic myeloid leukemia (CML) seems to have dramatically improved over the last two decades. Accurate information of the global burden of CML is critical for direct health policy and healthcare resource allocation in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Qingqing, Mao, Liping, Shao, Li, Zhu, Li, Han, Qingmei, Zhu, Honghu, Jin, Jie, You, Liangshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770240/
https://www.ncbi.nlm.nih.gov/pubmed/33384954
http://dx.doi.org/10.3389/fonc.2020.580759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7770240/
https://www.ncbi.nlm.nih.gov/pubmed/33384954
http://dx.doi.org/10.3389/fonc.2020.580759

Ejemplares similares